Skip to Content

Cardiogenetics, Volume 13, Issue 1

2023 March - 5 articles

Cover Story: Arrhythmogenic cardiomyopathy (ACM) is an inherited multi-faceted cardiac disease that causes sudden cardiac death. Recent clinical studies have recognized that ventricular arrhythmias were the underlying cause of death in post-COVID-19 patients due to established systemic inflammation associated with viral myocarditis. Currently, the available therapeutic options for treating this disease are either pharmacological or non-pharmacological. The most commonly used option includes an implantable cardioverter defibrillator (ICD) that can prevent further life-threatening actions of fibrillation. However, one of the only other options is heart transplantation. Therefore, there is an imperative need to tackle all these forms of ACM, which might be possible due to genome editing technology. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Article
  • Open Access
6 Citations
5,435 Views
14 Pages

Salt sensitivity is a trait in which high dietary sodium (Na+) intake causes an increase in blood pressure (BP). We previously demonstrated that in the gut, elevated dietary Na+ causes dysbiosis. The mechanistic interplay between excess dietary Na+-i...

(This article belongs to the Section Molecular & Translational Genetics)
  • Editorial
  • Open Access
2,924 Views
2 Pages

Arrhythmogenic cardiomyopathy (ACM) is an inherited multifaceted cardiac disease that causes sudden cardiac death, especially in young adults and athletes [...]

(This article belongs to the Section Cardiovascular Genetics in Clinical Practice)
  • Article
  • Open Access
9 Citations
7,882 Views
16 Pages

Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients

  • Tetiana A. Berezina,
  • Mykola P. Kopytsya,
  • Olga V. Petyunina,
  • Alexander A. Berezin and ,
  • Zeljko Obradovic,
  • Lukas Schmidbauer,
  • Michael Lichtenauer and
  • Alexander E. Berezin
  • + 3 authors+ 0 author

Cell-free nuclear (cf-nDNA) and mitochondrial (cf-mDNA) DNA are released from damaged cells in type 2 diabetes mellitus (T2DM) patients, contributing to adverse cardiac remodeling, vascular dysfunction, and inflammation. The purpose of this study was...

(This article belongs to the Section Molecular & Translational Genetics)
  • Article
  • Open Access
3,910 Views
13 Pages

Anti-Ischemic Effect of Leptin in the Isolated Rat Heart Subjected to Global Ischemia-Reperfusion: Role of Cardiac-Specific miRNAs

  • Ekaterina A. Polyakova,
  • Evgeny N. Mikhaylov,
  • Sarkis M. Minasian,
  • Mikhail M. Galagudza and
  • Evgeny V. Shlyakhto

Background: Leptin is an obesity-associated adipokine that has been implicated in cardiac protection against ischemia-reperfusion injury (IRI). In this study, concentration-dependent effects of leptin on myocardial IRI were investigated in the isolat...

(This article belongs to the Section Molecular & Translational Genetics)
XFacebookLinkedIn
Cardiogenetics - ISSN 2035-8148